HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GATA2 Transcription Factor

An essential GATA transcription factor that is expressed primarily in HEMATOPOIETIC STEM CELLS.
Also Known As:
GATA-Binding Protein 2; NFE1B Erythroid Transcription Factor; Nuclear Factor-Erythroid 1B; Transcription Factor GATA-2; GATA Binding Protein 2; GATA-2, Transcription Factor; Nuclear Factor Erythroid 1B; Transcription Factor GATA 2; Transcription Factor, GATA2
Networked: 62 relevant articles (0 outcomes, 7 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Holland, Steven M: 6 articles (01/2022 - 04/2013)
2. Hsu, Amy P: 5 articles (01/2022 - 04/2013)
3. Calvo, Katherine R: 4 articles (01/2022 - 02/2014)
4. Hickstein, Dennis D: 4 articles (01/2022 - 02/2014)
5. Wang, Weixin: 3 articles (01/2022 - 11/2020)
6. Bresnick, Emery H: 3 articles (11/2020 - 09/2017)
7. Johnson, Kirby D: 3 articles (11/2020 - 09/2017)
8. Chen, Lei: 3 articles (09/2016 - 06/2013)
9. Jiang, Beihai: 3 articles (09/2016 - 06/2013)
10. Su, Xiangqian: 3 articles (09/2016 - 06/2013)

Related Diseases

1. Myelodysplastic Syndromes (Myelodysplastic Syndrome)
2. Hematologic Neoplasms (Hematological Malignancy)
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/15/2012 - "In a recent issue of Cell, Kumar and colleagues uncovered a synthetic lethal interaction between oncogenic KRAS and the transcription factor GATA2 in non-small cell lung carcinoma. "
08/04/2014 - "In this study, we exploited a therapeutic strategy based on the interaction between GATA binding protein 2 (GATA2) downregulation and the KRAS mutation status by delivering small interfering RNA targeting GATA2 (siGATA2) with cationic lipid-assisted polymeric nanoparticles for treatment of non-small-cell lung carcinoma (NSCLC) harboring oncogenic KRAS mutations. "
12/01/2022 - ": ADPN: adiponectin; aP2: adipocyte protein 2 or fatty acid binding protein 4 (FABP4); BCA: bicinchoninic acid assay; BFA: bafilomycin A1; BMI: body mass index; C/EBP: CCAAT/enhancer binding protein; CEBPA: CCAAT/enhancer-binding protein-alpha; C-Exo: cancer cell-derived exosomes; CNTL: control; CREB: cAMP-response element binding protein; CytoD: cytochalasin D; ECL: chemiluminescence; GATA2: GATA Binding Protein 2; HFD: high fat diet; HSL: hormone-sensitive lipase; IGFBP4: insulin like growth factor binding protein 4; IRS-1: insulin receptor substrate-1; ISO: isoproterenol hydrochloride; KD: knockdown; KO: knock out; LC3: microtubule-associated protein 1A/1B-light chain 3; LMF: lipid mobilizing factor; LPL: lipoprotein lipase; MMP15: matrix metallopeptidase 15; Mir-Inh-C-Exo: cancer cell-derived exosomes with miR-425-3p inhibition; mTOR: mammalian target of rapamycin; Mut: mutant; N-Exo: normal cell-derived exosomes; NSCLC: non-small cell lung cancer; PBS, phosphate buffered saline; PGC-1: peroxisome proliferator-activated receptor-gamma coactivator-1; PDEs: phosphodiesterases; PKI: PKA inhibitor; PKA: cAMP-dependent protein kinase; PLIN1: Perilipin 1; PTHRP: parathyroid hormone-related protein; PVDF: polyvinylidene difluoride; shRNA: short hairpin RNA; UCP1: uncoupling protein 1; WT: wild type."
4. Aplastic Anemia (Anemia, Hypoplastic)
5. Adenomyosis

Related Drugs and Biologics

1. Transcription Factors (Transcription Factor)
2. Small Interfering RNA (siRNA)
3. Aquaporin 4
4. Peroxisome Proliferator-Activated Receptors (PPAR)
5. Lipids
6. Proteins (Proteins, Gene)
7. GATA2 Transcription Factor
8. CCAAT-Enhancer-Binding Protein-alpha
9. Messenger RNA (mRNA)
10. Carrier Proteins (Binding Protein)

Related Therapies and Procedures

1. Stem Cell Transplantation